Pharma & Biotech

Altimmune finds itself at a crossroads this week, presenting its investment case at the H.C. Wainwright Global Investment Conference while...

A significant regulatory development from the US Food and Drug Administration (FDA) is poised to fast-track Philip Morris International's strategic...

Iovance Biotherapeutics finds itself navigating a complex landscape where significant regulatory achievements contrast sharply with persistent financial headwinds. The company's...

Shares of Laboratory Corp. of America are attracting significant investor attention following a series of positive developments. The company recently...

CEO Mark Erlander is scheduled to present today at the H.C. Wainwright Global Investment Conference, marking the company's third major...

While broader markets posted gains in the latest session, AbbVie Inc. shares demonstrated a more measured performance. Behind this surface...

Amgen Inc. shares could be poised for a significant sentiment shift following two strategically important announcements from the biotechnology giant....

A surprising quarterly loss isn't dimming Wall Street's enthusiasm for medical device company Orthofix Medical. While the firm recently reported...

Guardant Health has received two significant boosts that could finally deliver the growth trajectory investors have been anticipating. After recent...

Investors are closely monitoring Astria Therapeutics as the biopharmaceutical company approaches a significant catalyst that could determine its near-term trajectory....